Clinical Evaluation Software for Molecular Analysis of Oncology Patients' Biomaterial "Solo-Report" According to TU 58.29.32-003-91709359-2018

Clinical Evaluation Software for Molecular Analysis of Oncology Patients' Biomaterial "Solo-Report" According to TU 58.29.32-003-91709359-2018

The "Solo-Report" software is designed for clinical evaluation of molecular research results based on patients' biomaterial in oncology. Developed in compliance with technical specifications TU 58.29.32-003-91709359-2018, this software supports the interpretation and assessment of genetic and molecular diagnostics data in clinical practice.

If your organization wants to sell medical equipment, medical products or medical consumables in Russia, for example, Clinical Evaluation Software for Molecular Analysis of Oncology Patients' Biomaterial "Solo-Report" According to TU 58.29.32-003-91709359-2018, then our information portal MEDCOMMERCE can help you with this. To do this, simply fill out the feedback form by clicking on the link FEEDBACK FORM.

The products posted on our website are approved for use in Russia by the state regulator Roszdravnadzor (Federal Service for Surveillance in Healthcare). The information is for informational purposes only.